NCT02792062View on ClinicalTrials.gov

A Food Effect Study of TAK-385 Final Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 4, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Japanese Premenopausal Healthy Adult Women
Interventions
DRUG

TAK-385 40 mg

TAK-385 40 mg tablet

Trial Locations (1)

Unknown

Fukuoka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02792062 - A Food Effect Study of TAK-385 Final Formulation | Biotech Hunter | Biotech Hunter